Tazmeen N. Fadra
Boehringer Ingelheim (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Estrogen and related hormone effects, Synthesis of Tetrazole Derivatives, Cancer Mechanisms and Therapy, Synthesis and biological activity
Most-Cited Works
- → Trifluoromethyl group as a pharmacophore: Effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand(2005)106 cited
- → Nonsteroidal Dissociated Glucocorticoid Agonists Containing Azaindoles as Steroid A-Ring Mimetics(2010)45 cited
- → Identification of Highly Efficacious Glucocorticoid Receptor Agonists with a Potential for Reduced Clinical Bone Side Effects(2014)31 cited
- → Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase(2006)29 cited
- → Discovery and Optimization of p38 Inhibitors via Computer-Assisted Drug Design(2007)24 cited
- → Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase(2008)23 cited
- → Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores(2011)19 cited
- → New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site(2007)15 cited
- → Discovery and characterization of the N-phenyl-N′-naphthylurea class of p38 kinase inhibitors(2009)7 cited